Product Information

DILTIAZEM 12HR ER 60 MG CAP is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $1.3431 per EA under NDC 68462085001. Its NADAC has been published 292 times since Apr 14, 2021.

FDA first approved this application on Mar 22, 2021. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DILTIAZEM 12HR ER 60 MG CAP

Diltiazem Hydrochloride
$1.3431per EA

Strength

60 mg/1

NDC

68462085001

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

DILTIAZEM HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA212317

FDA Approved

3/22/2021

TE Code

AB1

On Market Since

3/22/2021

Pharmacological Classes

Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A4 Inhibitors

Price Statistics

The NADAC for DILTIAZEM 12HR ER 60 MG CAP has been published 292 times since Apr 14, 2021, and over the history we have for it it has declined 41.5%. The table below summarizes its recorded NADAC range and movement.

Current price$1.3431 per EA
All-time high$2.6517 (Aug 16, 2023)
All-time low$1.3431 (Oct 21, 2026)
52-week high$1.7362
52-week low$1.3431
Median price$1.9238
Average price$1.9722
Largest weekly change+27.9% (Jan 18, 2023)
Weeks tracked292
Tracking sinceApr 14, 2021

Price History

1W

0.0%

1M

-5.9%

3M

-13.4%

6M

-2.3%

1Y

-0.8%

3Y

-39.4%

5Y

-41.6%

All

-41.5%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DILTIAZEM 12HR ER 60 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for DILTIAZEM 12HR ER 60 MG CAP, manufactured by Glenmark Pharmaceuticals Inc., USA, is $1.3431 per EA (NDC 68462085001), effective Nov 11, 2026.

How has the price of DILTIAZEM 12HR ER 60 MG CAP changed over time?

Over the history we have for it, the NADAC for DILTIAZEM 12HR ER 60 MG CAP has declined 41.5%. It has been tracked across 292 weekly CMS publications since Apr 14, 2021.

What are the highest and lowest recorded NADAC prices for DILTIAZEM 12HR ER 60 MG CAP?

Since Apr 14, 2021, the NADAC for DILTIAZEM 12HR ER 60 MG CAP has ranged from a low of $1.3431 (Oct 21, 2026) to a high of $2.6517 (Aug 16, 2023), with a median of $1.9238 per EA.

Are there cheaper alternatives to DILTIAZEM 12HR ER 60 MG CAP?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DILTIAZEM 12HR ER 60 MG CAP in a comparable dosage form, but none are currently priced below it.

Who manufactures DILTIAZEM 12HR ER 60 MG CAP?

DILTIAZEM 12HR ER 60 MG CAP (NDC 68462085001) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.